RT Journal Article
SR Electronic
T1 Denosumab: A novel antiresorptive drug for osteoporosis
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 105
OP 114
DO 10.3949/ccjm.82a.13173
VO 82
IS 2
A1 Ernest Suresh
A1 Bo Abrahamsen
YR 2015
UL http://www.ccjm.org/content/82/2/105.abstract
AB Denosumab is a novel antiresorptive drug that has been approved for use as a first-line drug for primary and secondary prevention of osteoporotic fractures. The authors discuss the mechanism of action of denosumab, review the evidence for its efficacy and safety in patients with osteoporosis, and offer recommendations for its use in clinical practice.